 The EVEREST II HRR is a single-arm prospective, multicenter clinical trial enrolling high surgical risk patients. Patients were considered high surgical risk if either their Society of Thoracic Surgery STS predicted operative mortality risk was 12, or the surgeon investigator determined the patient to be high risk 12 predicted operative mortality risk due to the presence of, at a minimum, one of the following pre-specified risk factors: 